Use of radiologic techniques to screen for hepatocellular carcinoma

Journal of Clinical Gastroenterology

Volumn 35, Issue 5 SUPPL., 2002, Pages

  Federle, Michael P ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Hepatocellular carcinoma; Radiologic techniques; Screening

Indexed keywords

TUMOR MARKER;

CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FATTY LIVER; HUMAN; LIVER ANGIOGRAPHY; LIVER BIOPSY; LIVER BLOOD FLOW; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER NODULE; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL HYPERTENSION; PRIORITY JOURNAL;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MASS SCREENING; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 0036842453     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200211002-00005     Document Type: Conference Paper

References (29)

1. Nzeako VC, Goodman ZD, Ishak KG. Hepatocellular carcinoma in cirrhotic and noncirrhotic livers: A clinico-histopathologic study of 804 North American patients. Am J Clin Pathol 1996;105:65-75.
2. Brancatelli G, Federle MP, Grazioli L, et al. Hepatocellular carcinoma in non-cirrhotic liver: CT. clinical, and pathologic findings in 39 US residents. Radiology 2002;222:89-94.
3. Ohtomo K, Baron RL, Dodd GD III, et al. Confluent hepatic fibrosis in advanced cirrhosis: Appearance at CT. Radiology. 1993;188:31-5.
4. Ohtomo K, Baron RL, Dodd GD III, et al. Confluent hepatic fibrosis in advanced cirrhosis: Evaluation with MR. Radiology 1993;189:871-4.
5. Murakami T, Nakamura H, Hoi S, et al. CT and MRI of siderotic regenerating nodules in cirrhotic liver. J Comput Assist Tomogr 1992;16:578-82.
6. Ohtomo K, Stoi Y, Ohtomo Y, et al. Regenerating nodules of liver cirrhosis: MR imaging with pathologic correlation. AJR Am J Roentgenol 1990;154:505-7.
7. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: Adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991;22:172-8.
8. Takayama T, Makuuchi M, Hirohashi S, et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 1990;336:1150-3.
9. Tanaka S, Kitamura T, Fujita M, et al. Small hepatocellular carcinoma: Differentiation from adenomatous hyperplastic nodule with color Doppler flow imaging. Radiology 1992;182:161-5.
10. Lim JH, Kim CK, Lee WJ, et al. Detection of hepatocellular carcinoma and dysplastic nodules in cirrhotic livers: Accuracy of helical CT in transplant patients. AJR Am J Roentgenol 2000;175:693-8.
11. Matsui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic livers: Distinction based on blood supply. Radiology 1991;178:493-7.
12. Ebara M, Ohto M, Waranabe Y, et al. Diagnosis of small hepatocellular carcinoma: Correlation of MR imaging and tumor histologic studies. Radiology 1986;159:371-7.
13. Krinsky GA, Lee VS, Theise ND, et al. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: Prospective diagnosis with MR imaging and explantation correlation. Radiology 2001;219:445-54.
14. Wilson SR, Burns PN. Liver mass evaluation with ultrasound: The impact of microbubble contrast agents and pulse inversion imaging. Semin Liver Dis 2001;21:147-59.
15. Federle MP, Blachar A. CT evaluation of the liver: Principles and techniques. Semin Liver Dis 2001;21:135-46.
16. Beavers KL, Semelka RC. MRI evaluation of the liver. Semin Liver Dis 2001;21:161-94.
17. Dodd GD III, Baron RL, Oliver JH III, et al. Spectrum of imaging findings in end-stage cirrhosis: Part II, focal abnormalities. AJR Am J Roentgenol 1999;173:1185-92.
18. Brancatelli G, Federle MP, Blachar A, et al. Hemangioma in the cirrhotic liver: Diagnosis and natural history. Radiology 2001;219:69-74.
19. Murakami T, Mochizaki K, Nakamura H. Imaging evaluation of the cirrhotic liver. Semin Liver Dis 2001;21:213-24.
20. Mori K, Yoshioka H, Itai Y, et al. Arterioportal shunts in cirrhotic patients: Evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide. AJR Am J Roentgenol 2000;175:1659-64.
21. Murakami T, Kim T, Takamura M, et al. Hypervascular hepatocellular carcinoma: Detection with double arterial phase multi-detector row helical Ct. Radiology 2001;218:763-7.
22. Kadoya M, Matsui O, Takashima T, et al. Hepatocellular carcinoma: Correlation of MR imaging and histologic findings. Radiology 1992;183:819-25.
23. Murakami T, Baron RL, Federle MP, et al. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology 1996;2000:69-77.
24. Peterson MS, Baron RL, Marsh JW Jr, et al. Pretransplant surveillance for possible hepatocellular carcinoma in patients with cirrhosis: Epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology 2000;217:743-749.
25. Arii S, Tobe T. Results of surgical treatment. Follow-up study by liver cancer study group of Japan. In: Tobe T, et al., eds. Primary Liver Cancer in Japan. Tokyo: Springer-Verlag: 1992:243-55.
26. Mor E, Kaspa RT, Sheiner P, et al. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 1998;15:129:643-53.
27. Achkar JP, Araya V, Baron RL, et al. Undetected hepatocellular carcinoma: Clinical features and outcome after liver transplantation. Liver Transpl Surg 1998;4:477-82.
28. Ebara M, Ohto M, Shinagawa T, et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis: A study in 22 patients. Gastroenterology 1986;90:289-98.
29. Kaneko S, Unoura M, Kobayashi K. Early detection of hepatocellular carcinoma. In: Ohuda K, Tabor E, eds. Liver Cancer. New York, Churchill Livingstone; 1997:393-406.